108 related articles for article (PubMed ID: 9754917)
1. Biochemical, cellular and pharmacological activities of a human neuropeptide FF-related peptide.
Gelot A; Mazarguil H; Dupuy P; Francés B; Gouardères C; Roumy M; Zajac JM
Eur J Pharmacol; 1998 Aug; 354(2-3):167-72. PubMed ID: 9754917
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide FF, pain and analgesia.
Roumy M; Zajac JM
Eur J Pharmacol; 1998 Mar; 345(1):1-11. PubMed ID: 9593588
[TBL] [Abstract][Full Text] [Related]
3. Effects of neuropeptide FF analogs on morphine analgesia in the nucleus raphe dorsalis.
Dupouy V; Zajac JM
Regul Pept; 1995 Nov; 59(3):349-56. PubMed ID: 8577940
[TBL] [Abstract][Full Text] [Related]
4. Antisense oligonucleotides to human SQA-neuropeptide FF decrease morphine tolerance and dependence in mice.
Gelot A; Francés B; Gicquel S; Zajac JM
Eur J Pharmacol; 1998 Oct; 358(3):203-6. PubMed ID: 9822885
[TBL] [Abstract][Full Text] [Related]
5. Role of adenosine in the spinal antinociceptive and morphine modulatory actions of neuropeptide FF analogs.
Gouardères C; Sutak M; Zajac JM; Jhamandas K
Eur J Pharmacol; 2000 Oct; 406(3):391-401. PubMed ID: 11040346
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide FF receptors control morphine-induced analgesia in the parafascicular nucleus and the dorsal raphe nucleus.
Dupouy V; Zajac JM
Eur J Pharmacol; 1997 Jul; 330(2-3):129-37. PubMed ID: 9253945
[TBL] [Abstract][Full Text] [Related]
7. Dissociation of pharmacological pro- and anti-opioid effects by neuropeptide FF analogs.
Quelven I; Roussin A; Burlet-Schiltz O; Gouardères C; Tafani JA; Mazarguil H; Zajac JM
Eur J Pharmacol; 2002 Aug; 449(1-2):91-8. PubMed ID: 12163111
[TBL] [Abstract][Full Text] [Related]
8. Anti-opioid efficacy of neuropeptide FF in morphine-tolerant mice.
Gelot A; Francés B; Roussin A; Latapie JP; Zajac JM
Brain Res; 1998 Oct; 808(2):166-73. PubMed ID: 9767158
[TBL] [Abstract][Full Text] [Related]
9. Hypothermic effects of neuropeptide FF analogues in mice.
Desprat C; Zajac JM
Pharmacol Biochem Behav; 1997 Oct; 58(2):559-63. PubMed ID: 9300619
[TBL] [Abstract][Full Text] [Related]
10. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues.
Gouardères C; Jhamandas K; Sutak M; Zajac JM
Br J Pharmacol; 1996 Feb; 117(3):493-501. PubMed ID: 8821539
[TBL] [Abstract][Full Text] [Related]
11. Effects of neuropeptide FF on intracellular Ca2+ in mouse spinal ganglion neurons.
Roumy M; Zajac JM
Eur J Pharmacol; 1996 Jun; 306(1-3):291-5. PubMed ID: 8813643
[TBL] [Abstract][Full Text] [Related]
12. Affinity of neuropeptide FF analogs to opioid receptors in the rat spinal cord.
Gouardères C; Tafani JA; Zajac JM
Peptides; 1998; 19(4):727-30. PubMed ID: 9622028
[TBL] [Abstract][Full Text] [Related]
13. Comparative action of Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 analogs on intestinal motility and nociception in rats.
Million M; Fioramonti J; Gicquel S; Zajac JM; Bueno L
J Pharmacol Exp Ther; 1993 Apr; 265(1):96-102. PubMed ID: 8474035
[TBL] [Abstract][Full Text] [Related]
14. Central effects of neuropeptide FF on intestinal motility in naive and morphine-dependent rats.
Gelot A; Fioramonti J; Zajac JM; Bueno L
Neuropeptides; 1995 Nov; 29(5):245-50. PubMed ID: 8587659
[TBL] [Abstract][Full Text] [Related]
15. Identification of neuropeptide FF-related peptides in rodent spinal cord.
Bonnard E; Burlet-Schiltz O; Francés B; Mazarguil H; Monsarrat B; Zajac JM; Roussin A
Peptides; 2001 Jul; 22(7):1085-92. PubMed ID: 11445238
[TBL] [Abstract][Full Text] [Related]
16. Analogues of F8Famide resistant to degradation, with high affinity and in vivo effects.
Gicquel S; Mazarguil H; Allard M; Simonnet G; Zajac JM
Eur J Pharmacol; 1992 Nov; 222(1):61-7. PubMed ID: 1468500
[TBL] [Abstract][Full Text] [Related]
17. Opposing interplay between Neuropeptide FF and nitric oxide in antinociception and hypothermia.
Zajac JM; Latapie JP; Francés B
Peptides; 2000 Aug; 21(8):1209-13. PubMed ID: 11035207
[TBL] [Abstract][Full Text] [Related]
18. Functional consequences of neuropeptide FF receptors stimulation in mouse: a cerebral glucose uptake study.
Quelven I; Roussin A; Zajac JM
Neuroscience; 2004; 126(2):441-9. PubMed ID: 15207362
[TBL] [Abstract][Full Text] [Related]
19. Enzymatic degradation of neuropeptide FF and SQA-neuropeptide FF in the mouse brain.
Sol JC; Roussin A; Proto S; Mazarguil H; Zajac JM
Peptides; 1999; 20(10):1219-27. PubMed ID: 10573294
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide FF reverses the effect of mu-opioid on Ca2+ channels in rat spinal ganglion neurones.
Rebeyrolles S; Zajac JM; Roumy M
Neuroreport; 1996 Nov; 7(18):2979-81. PubMed ID: 9116223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
